Ataraxis AI and Unicancer Partner to Validate Ataraxis™ Breast Prognostic Tool Using Global Phase III Trial Data

Glencoe Software and CymaBay Therapeutics collaborated to digitally transform a pathology review workflow, which delivered on an NDA-enabling clinical trial requirement ahead of schedule. CymaBay Therapeutics, acquired by Gilead Sciences,...

BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics, the global leader in clinical-grade AI-powered pathology, today announced a significant expansion of its biopharma business. Building on its successful collaborations in late-stage biomarker...

The latest from the Proscia blog With the end of 2025 in sight, it’s only natural to ask what’s next, especially as digital pathology keeps advancing. Predictions are everywhere, and a lot of them are painfully obvious: adoption will...

NEW YORK--(BUSINESS WIRE)--Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, and Unicancer, the leading French network dedicated exclusively to cancer care and research, today...

Indica Labs: Learn how HALO and HALO AI are helping expand our understanding of immune regulation by different subtypes of cancer-associated fibroblasts! Highly multiplexed imaging reveals CAF-immune cell niches in cutaneous...

OREM, UT, UNITED STATES, December 30, 2025 /EINPresswire.com/ -- Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced the publication of a peer-reviewed study in Diagnostics...